
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Changes in Emergency Department Visits for Cannabis Hyperemesis Syndrome Following Recreational Cannabis Legalization and Subsequent Commercialization in Ontario, Canada
Daniel T. Myran, Rhiannon Roberts, Michael Pugliese, et al.
JAMA Network Open (2022) Vol. 5, Iss. 9, pp. e2231937-e2231937
Open Access | Times Cited: 39
Daniel T. Myran, Rhiannon Roberts, Michael Pugliese, et al.
JAMA Network Open (2022) Vol. 5, Iss. 9, pp. e2231937-e2231937
Open Access | Times Cited: 39
Showing 1-25 of 39 citing articles:
The Impact of Recreational Cannabis Legalization on Cannabis Use and Associated Outcomes: A Systematic Review
Kyra N. Farrelly, Jeffrey D. Wardell, Emma Marsden, et al.
Substance Abuse Research and Treatment (2023) Vol. 17
Open Access | Times Cited: 65
Kyra N. Farrelly, Jeffrey D. Wardell, Emma Marsden, et al.
Substance Abuse Research and Treatment (2023) Vol. 17
Open Access | Times Cited: 65
The association between physical availability of cannabis retail outlets and frequent cannabis use and related health harms: a systematic review
Nathan Cantor, Max Silverman, Adrienne Gaudreault, et al.
The Lancet Regional Health - Americas (2024) Vol. 32, pp. 100708-100708
Open Access | Times Cited: 17
Nathan Cantor, Max Silverman, Adrienne Gaudreault, et al.
The Lancet Regional Health - Americas (2024) Vol. 32, pp. 100708-100708
Open Access | Times Cited: 17
Access to legal cannabis market in Canada over the four years following non‐medical cannabis legalisation
Daniel T. Myran, Erik Loewen Friesen, Sarah Dickson, et al.
Drug and Alcohol Review (2023) Vol. 42, Iss. 5, pp. 1114-1119
Open Access | Times Cited: 30
Daniel T. Myran, Erik Loewen Friesen, Sarah Dickson, et al.
Drug and Alcohol Review (2023) Vol. 42, Iss. 5, pp. 1114-1119
Open Access | Times Cited: 30
Changes in Cannabis-Attributable Hospitalizations Following Nonmedical Cannabis Legalization in Canada
Daniel T. Myran, Adrienne Gaudreault, Lauren Konikoff, et al.
JAMA Network Open (2023) Vol. 6, Iss. 10, pp. e2336113-e2336113
Open Access | Times Cited: 22
Daniel T. Myran, Adrienne Gaudreault, Lauren Konikoff, et al.
JAMA Network Open (2023) Vol. 6, Iss. 10, pp. e2336113-e2336113
Open Access | Times Cited: 22
Outcomes associated with nonmedical cannabis legalization policy in Canada: taking stock at the 5-year mark
Benedikt Fischer, Didier Jutras‐Aswad, Wayne Hall
Canadian Medical Association Journal (2023) Vol. 195, Iss. 39, pp. E1351-E1353
Open Access | Times Cited: 22
Benedikt Fischer, Didier Jutras‐Aswad, Wayne Hall
Canadian Medical Association Journal (2023) Vol. 195, Iss. 39, pp. E1351-E1353
Open Access | Times Cited: 22
Cannabidiol-Derived Cannabinoids: The Unregulated Designer Drug Market Following the 2018 Farm Bill
Charles N. Zawatsky, Sara Mills‐Huffnagle, Corinne Augusto, et al.
Medical Cannabis and Cannabinoids (2024) Vol. 7, Iss. 1, pp. 10-18
Open Access | Times Cited: 10
Charles N. Zawatsky, Sara Mills‐Huffnagle, Corinne Augusto, et al.
Medical Cannabis and Cannabinoids (2024) Vol. 7, Iss. 1, pp. 10-18
Open Access | Times Cited: 10
Acute care related to cannabis use during pregnancy after the legalization of nonmedical cannabis in Ontario
Daniel T. Myran, Rhiannon Roberts, Michael Pugliese, et al.
Canadian Medical Association Journal (2023) Vol. 195, Iss. 20, pp. E699-E708
Open Access | Times Cited: 16
Daniel T. Myran, Rhiannon Roberts, Michael Pugliese, et al.
Canadian Medical Association Journal (2023) Vol. 195, Iss. 20, pp. E699-E708
Open Access | Times Cited: 16
The adverse public health effects of non-medical cannabis legalisation in Canada and the USA
Tesfa Mekonen Yimer, Eva Hoch, Benedikt Fischer, et al.
The Lancet Public Health (2025) Vol. 10, Iss. 2, pp. e148-e159
Open Access
Tesfa Mekonen Yimer, Eva Hoch, Benedikt Fischer, et al.
The Lancet Public Health (2025) Vol. 10, Iss. 2, pp. e148-e159
Open Access
Evaluating the association between cannabis decriminalization and legalization and cannabis arrests and related disparities: A Systematic review
Steven J McCarthy, Adrienne Gaudreault, Jennifer Xiao, et al.
International Journal of Drug Policy (2025) Vol. 137, pp. 104705-104705
Closed Access
Steven J McCarthy, Adrienne Gaudreault, Jennifer Xiao, et al.
International Journal of Drug Policy (2025) Vol. 137, pp. 104705-104705
Closed Access
Cannabis and psychopathology: 2024 Snapshot of a meandering journey
Tathagata Mahintamani, Diptadhi Mukherjee, Debasish Basu
Indian Journal of Psychiatry (2025) Vol. 67, Iss. 3, pp. 283-302
Open Access
Tathagata Mahintamani, Diptadhi Mukherjee, Debasish Basu
Indian Journal of Psychiatry (2025) Vol. 67, Iss. 3, pp. 283-302
Open Access
Impacts of recreational cannabis legalization on use and harms: A narrative review of sex/gender differences
Justin Matheson, Bernard Le Foll
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 15
Justin Matheson, Bernard Le Foll
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 15
Understanding youth and young adult cannabis use in Canada post-legalization: a scoping review on a public health issue
Toula Kourgiantakis, Ragave Vicknarajah, Judith Logan, et al.
Substance Abuse Treatment Prevention and Policy (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 4
Toula Kourgiantakis, Ragave Vicknarajah, Judith Logan, et al.
Substance Abuse Treatment Prevention and Policy (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 4
Policies and Regulations Regarding Adolescent Marijuana Use—Reply
Li Wang, Jason W. Busse
JAMA Pediatrics (2025)
Closed Access
Li Wang, Jason W. Busse
JAMA Pediatrics (2025)
Closed Access
Association of Cannabis Legalization With Prevalence of Schizophrenia—Challenges of Attributing Biological Causality to Policy Change
Jodi M. Gilman
JAMA Network Open (2025) Vol. 8, Iss. 2, pp. e2457876-e2457876
Open Access
Jodi M. Gilman
JAMA Network Open (2025) Vol. 8, Iss. 2, pp. e2457876-e2457876
Open Access
The effect of recreational cannabis legalization and commercialization on substance use, mental health, and injury: a systematic review
Madison Walker, Melissa Carpino, David Lightfoot, et al.
Public Health (2023) Vol. 221, pp. 87-96
Open Access | Times Cited: 10
Madison Walker, Melissa Carpino, David Lightfoot, et al.
Public Health (2023) Vol. 221, pp. 87-96
Open Access | Times Cited: 10
SAEM GRACE: Dopamine antagonists and topical capsaicin for cannabis hyperemesis syndrome in the emergency department: A systematic review of direct evidence
Monica Sabbineni, William H. Scott, Kiran Punia, et al.
Academic Emergency Medicine (2023) Vol. 31, Iss. 5, pp. 493-503
Closed Access | Times Cited: 8
Monica Sabbineni, William H. Scott, Kiran Punia, et al.
Academic Emergency Medicine (2023) Vol. 31, Iss. 5, pp. 493-503
Closed Access | Times Cited: 8
Youth cannabis use in Canada post-legalization: service providers’ perceptions, practices, and recommendations
Toula Kourgiantakis, Eunjung Lee, A. Kumsal Tekirdag Kosar, et al.
Substance Abuse Treatment Prevention and Policy (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 7
Toula Kourgiantakis, Eunjung Lee, A. Kumsal Tekirdag Kosar, et al.
Substance Abuse Treatment Prevention and Policy (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 7
Trends of emergency department visits for cannabinoid hyperemesis syndrome in Nevada: An interrupted time series analysis
Jae Seung Soh, Yonsu Kim, Jay J. Shen, et al.
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0303205-e0303205
Open Access | Times Cited: 2
Jae Seung Soh, Yonsu Kim, Jay J. Shen, et al.
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0303205-e0303205
Open Access | Times Cited: 2
Neuromodulation for Cannabis Use: A Scoping Review
Anthony Ngoy, Victor M. Tang, Kebin Xiao, et al.
Brain Sciences (2024) Vol. 14, Iss. 4, pp. 356-356
Open Access | Times Cited: 1
Anthony Ngoy, Victor M. Tang, Kebin Xiao, et al.
Brain Sciences (2024) Vol. 14, Iss. 4, pp. 356-356
Open Access | Times Cited: 1
Implications of cannabis legalization for the US federal budget
Alex Brill, Brian J. Miller, Stan Veuger
Public Budgeting & Finance (2024) Vol. 44, Iss. 3, pp. 22-43
Open Access | Times Cited: 1
Alex Brill, Brian J. Miller, Stan Veuger
Public Budgeting & Finance (2024) Vol. 44, Iss. 3, pp. 22-43
Open Access | Times Cited: 1
Clinician perspectives on adolescent Cannabis-Related beliefs and behaviors following recreational cannabis legalization
Kelly C. Young‐Wolff, Monique B. Does, Maha N. Mian, et al.
Addictive Behaviors (2024) Vol. 156, pp. 108046-108046
Closed Access | Times Cited: 1
Kelly C. Young‐Wolff, Monique B. Does, Maha N. Mian, et al.
Addictive Behaviors (2024) Vol. 156, pp. 108046-108046
Closed Access | Times Cited: 1
Changes in cannabis involvement in emergency department visits for anxiety disorders after cannabis legalization: a repeated cross-sectional study
Stephen D.S. McCarthy, Jennifer Xiao, Michael Pugliese, et al.
The Lancet Regional Health - Americas (2024) Vol. 36, pp. 100815-100815
Open Access | Times Cited: 1
Stephen D.S. McCarthy, Jennifer Xiao, Michael Pugliese, et al.
The Lancet Regional Health - Americas (2024) Vol. 36, pp. 100815-100815
Open Access | Times Cited: 1
An early economic analysis of medical cannabis for the treatment of chronic pain
Shanna Marrinan, Anne Katrin Schlag, Michael T. Lynskey, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2024), pp. 1-14
Closed Access | Times Cited: 1
Shanna Marrinan, Anne Katrin Schlag, Michael T. Lynskey, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2024), pp. 1-14
Closed Access | Times Cited: 1
Reducing the harms of cannabis use in youth post-legalization: insights from Ontario youth, parents, and service providers
Toula Kourgiantakis, Angie Hamilton, Christine Tait, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Toula Kourgiantakis, Angie Hamilton, Christine Tait, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Cannabis Use Patterns and Whole-Blood Cannabinoid Profiles of Emergency Department Patients With Suspected Cannabinoid Hyperemesis Syndrome
Rachel Wightman, Jane Metrik, Timmy R. Lin, et al.
Annals of Emergency Medicine (2023) Vol. 82, Iss. 2, pp. 121-130
Open Access | Times Cited: 3
Rachel Wightman, Jane Metrik, Timmy R. Lin, et al.
Annals of Emergency Medicine (2023) Vol. 82, Iss. 2, pp. 121-130
Open Access | Times Cited: 3